RayThera is a recently founded biotechnology company focused on discovering and developing small molecule therapies in immunology. The company is building an immunology pipeline and advancing lead drug candidates toward clinical testing. Proceeds from its recent financing will be used to advance lead candidates through Phase 1 clinical studies and to support the preclinical immunology pipeline. RayThera is led by co-founders Qing Dong and Gene Hung and a team of experienced drug hunters and executives with prior track records in biotech and pharma. The company is based in San Diego, CA. Investors and company statements emphasize support from a returning syndicate that previously backed the founders' prior venture, XinThera.

Total raised

$110M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2025